• 1
    Klutmann S, Bohuslavizki KH, Kroger S, et al. Quantitative salivary gland scintigraphy. J Nucl Med Technol 1999; 27: 2026.
  • 2
    Bohuslavizki KH, Brenner W, Lassmann S, et al. Quantitative salivary gland scintigraphy: a recommended examination prior to and after radioiodine therapy [in German]. Nuklearmedizin 1997; 36: 103109.
  • 3
    Wang J, Takashima S, Takayama F, et al. Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology 2001; 220: 621630.
  • 4
    Yoshino N, Yamada I, Ohbayashi N, et al. Salivary glands and lesions: evaluation of apparent diffusion coefficients with split-echo diffusion-weighted MR imaging--initial results. Radiology 2001; 221: 837842.
  • 5
    Maeda M, Kato H, Sakuma H, Maier SE, Takeda K. Usefulness of the apparent diffusion coefficient in line scan diffusion-weighted imaging for distinguishing between squamous cell carcinomas and malignant lymphomas of the head and neck. AJNR Am J Neuroradiol 2005; 26: 11861192.
  • 6
    Sumi M, Van Cauteren M, Nakamura T. MR microimaging of benign and malignant nodes in the neck. AJR Am J Roentgenol 2006; 186: 749757.
  • 7
    Kawai Y, Sumi M, Kitamori H, Takagi Y, Nakamura T. Diffusion-weighted MR microimaging of the lacrimal glands in patients with Sjogren's syndrome. AJR Am J Roentgenol 2005; 184: 13201325.
  • 8
    Sumi M, Takagi Y, Uetani M, et al. Diffusion-weighted echoplanar MR imaging of the salivary glands. AJR Am J Roentgenol 2002; 178: 959965.
  • 9
    Sumi M, Sakihama N, Sumi T, et al. Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. AJNR Am J Neuroradiol 2003; 24: 16271634.
  • 10
    Abdel Razek AA, Soliman NY, Elkhamary S, Alsharaway MK, Tawfik A. Role of diffusion-weighted MR imaging in cervical lymphadenopathy. Eur Radiol 2006; 16: 14681477.
  • 11
    Vandecaveye V, de Keyzer F, Vander Poorten V, et al. Evaluation of the larynx for tumour recurrence by diffusion-weighted MRI after radiotherapy: initial experience in four cases. Br J Radiol 2006; 79: 681687.
  • 12
    Aikele P, Kittner T, Offergeld C, Kaftan H, Huttenbrink KB, Laniado M. Diffusion-weighted MR imaging in pediatric and adult patients who have undergone middle ear surgery. AJR Am J Roentgenol 2003; 181: 261265.
  • 13
    Dubrulle F, Souillard R, Chechin D, Vaneecloo FM, Desaulty A, Vincent C. Diffusion-weighted MR imaging sequence in the detection of postoperative recurrent cholesteatoma. Radiology 2006; 238: 604610.
  • 14
    Kato H, Kanematsu M, Tanaka O, et al. Head and neck squamous cell carcinoma: usefulness of diffusion-weighted MR imaging in the prediction of a neoadjuvant therapeutic effect. Eur Radiol 2009; 19: 103109.
  • 15
    Vandecaveye V, De Keyzer F, Nuyts S, et al. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys 2007; 67: 960971.
  • 16
    Galbán CJ, Mukherji SK, Chenevert TL, et al. A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl Oncol 2009; 2: 184190.
  • 17
    Thoeny HC, De Keyzer F, Claus FG, et al. Gustatory stimulation changes the apparent diffusion coefficient of salivary glands: initial experience. Radiology 2005; 235: 629634.
  • 18
    Habermann CR, Gossrau P, Kooijman H, et al. Monitoring of gustatory stimulation of salivary glands by diffusion-weighted MR imaging: comparison of 1.5T and 3T. AJNR Am J Neuroradiol 2007; 28: 15471551.
  • 19
    Ries T, Arndt C, Regier M, et al. Value of apparent diffusion coefficient calculation before and after gustatory stimulation in the diagnosis of acute or chronic parotitis. Eur Radiol 2008; 18: 22512257.
  • 20
    Dirix P, De Keyzer F, Vandecaveye V, et al. Diffusion-weighted magnetic resonance imaging to evaluate major salivary gland function before and after radiotherapy. Int J Radiat Oncol Biol Phys 2008; 71: 13651371.
  • 21
    Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554558.
  • 22
    Sreebny LM, Valdini A. Xerostomia. Part I. Relationship to other oral symptoms and salivary gland hypofunction. Oral Surg Oral Med Oral Pathol 1988; 66: 451458.
  • 23
    Guggenheimer J, Moore PA. Xerostomia: etiology, recognition and treatment. J Am Dent Assoc 2003; 134: 6169.
  • 24
    Thoeny HC, De Keyzer F, Boesch C, et al. Diffusion-weighted imaging of the parotid gland: influence of the choice of b-values on the apparent diffusion coefficient value. J Magn Reson Imaging 2004; 20: 786790.
  • 25
    Juan CJ, Chang HC, Hsueh CJ, et al. Salivary glands: echo-planar versus PROPELLER Diffusion-weighted MR imaging for assessment of ADCs. Radiology 2009; 253: 144152.
  • 26
    Zhang L, Murata Y, Ishida R, et al. Functional evaluation with intravoxel incoherent motion echo-planar MRI in irradiated salivary glands: a correlative study with salivary gland scintigraphy. J Magn Reson Imaging 2001; 14: 223229.
  • 27
    Patel RR, Carlos RC, Midia M, et al. Apparent diffusion coefficient mapping of the normal parotid gland and parotid involvement in patients with systemic connective tissue disorders. AJNR Am J Neuroradiol 2004; 25: 1620.
  • 28
    Percival RS, Challacombe SJ, Marsh PD. Flow rates of resting whole and stimulated parotid saliva in relation to age and gender. J Dent Res 1994; 73: 14161420.